Document detail

7 December 2021 These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19b2 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. This document has been updated: Version 19 November 2021.

Moderna,  vaccine,  COVID-19,  mRNA,